主页 > 医学新闻 >

Long-term results after the glycoprotein Iib/IIIa inhibitor

期刊名称:Circulation
英文题目:Long-term results after the glycoprotein Iib/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial.
文章来源:2003-01 ;107卷;437-42页
作者:Ottervanger JP 、Armstrong P、Simoons ML
英文摘要:
BACKGROUND: This study was designed to investigate long-term effects of the glycoprotein Iib/IIIa inhibitor abciximab in patients with acute coronary syndrome without ST elevation who were not scheduled for coronary intervention. METHODS AND RESULTS: A total of 7800 patients were included with an acute coronary syndrome without ST elevation, documented by either elevated cardiac troponin or transient or persistent ST-segment depression. They were randomized to abciximab bolus and 24-hour infusion, abciximab bolus and 48-hour infusion, or matching placebo. The overall 1-year mortality rate was 8.3% (649 patients). One-year mortality was 7.8% in the placebo group and 8.2% in the 24-hour and 9.0% in the 48-hour abciximab infusion group. Compared with placebo, the hazard ratio for the 24-hour infusion of abciximab was 1.1 (95% CI 0.86 to 1.29), and for the 48-hour infusion, it was 1.2 (95% CI 0.95 to 1.41). The lack of benefit of abciximab was observed in every subgroup studied. Patients with negative troponin or elevated C-reactive protein had a higher mortality rate after treatment with abciximab for 48 hours than with placebo: 8.5% versus 5.8% in those with negative troponin (P=0.02), 16.3% versus 12.1% in those with elevated C-reactive protein (P=0.04). CONCLUSIONS: Compared with placebo, abciximab did not provide any survival benefit at 1 year in patients admitted with an acute coronary syndrome with ST depression and/or elevated troponin who were not scheduled to undergo early coronary revascularization. In subgroups of patients, in particular those with low cardiac troponin or elevated C-reactive protein, abciximab was associated with excess mortality.
中文摘要:

英文关键词:Acute Coronary Syndromeanginaabciximabcoronary [标签:content1][标签:content2]

阅读本文的人还阅读:

【medical-news】简单的3个

【medical-news】肥胖与糖尿

【medical-news】PET/CT 应用

【drug-news】FDA 批准Medt

【JAMA】B族维生素无法减

作者:admin@医学,生命科学    2011-03-30 17:30
医学,生命科学网